Beurs gesloten -
Nyse
22:00:02 24-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
20,99
USD
|
-1,69%
|
|
-3,72%
|
+45,56%
|
Fiscaal tijdperk: december |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
7.721
|
7.104
|
3.686
|
5.398
|
-
|
-
|
Bedrijfswaarde
1 |
16.118
|
15.311
|
11.753
|
13.042
|
12.327
|
11.542
|
K/w-verhouding
|
5,73
x
|
7,78
x
|
3,61
x
|
7,24
x
|
5,6
x
|
5,08
x
|
Dividendrendement
|
1,84%
|
4,01%
|
7,77%
|
5,3%
|
5,51%
|
5,34%
|
Marktkapitalisatie/omzet
|
1,22
x
|
1,15
x
|
0,59
x
|
0,84
x
|
0,83
x
|
0,83
x
|
Bedrijfswaarde/omzet
|
2,56
x
|
2,48
x
|
1,88
x
|
2,04
x
|
1,91
x
|
1,76
x
|
Bedrijfswaarde/EBITDA
|
6,77
x
|
7,34
x
|
6,05
x
|
6,35
x
|
5,86
x
|
5,36
x
|
Bedrijfswaarde/FCF
|
8,19
x
|
23,1
x
|
21,4
x
|
16,4
x
|
11,7
x
|
10,3
x
|
FCF Yield
|
12,2%
|
4,32%
|
4,66%
|
6,11%
|
8,52%
|
9,72%
|
Price to Book
|
-
|
-7,99
x
|
-52,7
x
|
10,5
x
|
4,2
x
|
2,47
x
|
Aantal aandelen (in duizenden)
|
253.550
|
254.364
|
255.606
|
257.171
|
-
|
-
|
Referentieprijs
2 |
30,45
|
27,93
|
14,42
|
20,99
|
20,99
|
20,99
|
Datum van publicatie
|
17-02-22
|
16-02-23
|
15-02-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
8.096
|
6.304
|
6.174
|
6.263
|
6.391
|
6.467
|
6.542
|
EBITDA
1 |
-
|
2.379
|
2.085
|
1.944
|
2.055
|
2.105
|
2.155
|
Bedrijfsresultaat (EBIT)
1 |
-
|
2.184
|
1.873
|
1.874
|
1.930
|
1.979
|
2.031
|
Operationele Marge
|
-
|
34,64%
|
30,34%
|
29,92%
|
30,2%
|
30,6%
|
31,05%
|
Resultaat voor belastingen (EBT)
1 |
-
|
1.529
|
1.122
|
673
|
933
|
1.252
|
1.418
|
Nettowinst (verlies)
1 |
2.160
|
1.351
|
917
|
1.023
|
751
|
971
|
1.071
|
Nettomarge
|
26,68%
|
21,43%
|
14,85%
|
16,33%
|
11,75%
|
15,01%
|
16,37%
|
WPA
2 |
-
|
5,310
|
3,590
|
3,990
|
2,900
|
3,750
|
4,130
|
Free Cash Flow
1 |
-
|
1.968
|
662
|
548
|
796,5
|
1.050
|
1.121
|
FCF-marge
|
-
|
31,22%
|
10,72%
|
8,75%
|
12,46%
|
16,23%
|
17,14%
|
Kasstroomconversie (ebitda)
|
-
|
82,72%
|
31,75%
|
28,19%
|
38,75%
|
49,87%
|
52,04%
|
Kasstroomconversie (nettowinst)
|
-
|
145,67%
|
72,19%
|
53,57%
|
106,06%
|
108,1%
|
104,7%
|
Dividend per aandeel
2 |
-
|
0,5600
|
1,120
|
1,120
|
1,112
|
1,156
|
1,120
|
Datum van publicatie
|
14-04-21
|
17-02-22
|
16-02-23
|
15-02-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
1.604
|
1.567
|
1.585
|
1.537
|
1.485
|
1.538
|
1.608
|
1.519
|
1.598
|
1.622
|
1.627
|
1.556
|
1.573
|
1.570
|
1.609
|
EBITDA
1 |
549
|
647
|
512
|
546
|
380
|
518
|
530
|
447
|
449
|
538
|
531
|
509
|
507
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
487
|
594
|
462
|
489
|
328
|
461
|
472
|
430
|
436
|
475
|
505,5
|
475,2
|
473,3
|
494,7
|
505
|
Operationele Marge
|
30,36%
|
37,91%
|
29,15%
|
31,82%
|
22,09%
|
29,97%
|
29,35%
|
28,31%
|
27,28%
|
29,28%
|
31,07%
|
30,55%
|
30,08%
|
31,51%
|
31,38%
|
Resultaat voor belastingen (EBT)
|
236
|
-
|
287
|
282
|
111
|
235
|
254
|
80
|
104
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
|
202
|
-
|
234
|
227
|
108
|
177
|
242
|
58
|
546
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettomarge
|
12,59%
|
-
|
14,76%
|
14,77%
|
7,27%
|
11,51%
|
15,05%
|
3,82%
|
34,17%
|
-
|
-
|
-
|
-
|
-
|
-
|
WPA
|
0,7900
|
1,360
|
0,9200
|
0,8900
|
0,4200
|
0,6900
|
0,9500
|
0,2300
|
2,130
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
0,2800
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
17-02-22
|
05-05-22
|
04-08-22
|
03-11-22
|
16-02-23
|
04-05-23
|
08-08-23
|
02-11-23
|
15-02-24
|
02-05-24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
8.397
|
8.207
|
8.067
|
7.644
|
6.929
|
6.144
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
3,53
x
|
3,936
x
|
4,15
x
|
3,719
x
|
3,292
x
|
2,851
x
|
Free Cash Flow
1 |
-
|
1.968
|
662
|
548
|
797
|
1.050
|
1.121
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
67,9%
|
-
|
-
|
405%
|
118%
|
68,2%
|
ROA (netto-inkomsten/totale activa)
|
-
|
13%
|
11,9%
|
9,22%
|
9,65%
|
9,49%
|
9,54%
|
Totale activa
1 |
-
|
10.395
|
7.726
|
11.094
|
7.786
|
10.232
|
11.229
|
Nettoactief per aandeel
2 |
-
|
-
|
-3,500
|
-0,2700
|
2,000
|
5,000
|
8,500
|
Cashflow per aandeel
2 |
-
|
8,500
|
3,360
|
3,120
|
4,430
|
5,170
|
5,610
|
Capex
1 |
-
|
192
|
196
|
51
|
215
|
227
|
229
|
Capex/omzet
|
-
|
3,05%
|
3,17%
|
0,81%
|
3,36%
|
3,51%
|
3,5%
|
Datum van publicatie
|
14-04-21
|
17-02-22
|
16-02-23
|
15-02-24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
20,99
USD Gemiddelde koersdoel
22,5
USD Spread / Gemiddelde doel +7,19% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +45,56% | 5,4 mld. | | +38,51% | 727 mld. | | +33,05% | 599 mld. | | -6,23% | 354 mld. | | +18,78% | 328 mld. | | +1,35% | 277 mld. | | +16,00% | 243 mld. | | +8,09% | 205 mld. | | -5,77% | 203 mld. | | +6,19% | 164 mld. |
Farmaceutische producten - Andere
|